Cargando…
FDG–PET findings associated with various medical procedures and treatments
[(18)F]-fluorodeoxyglucose (FDG) positron emission tomography (PET) is a well-established modality with high sensitivity for the diagnosis and staging of oncologic patients. FDG is taken up by the glucose transporter of the cell membrane and becomes trapped within the cell. In addition to malignant...
Autores principales: | Okuyama, Chio, Higashi, Tatsuya, Ishizu, Koichi, Saga, Tsuneo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Nature Singapore
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9794480/ https://www.ncbi.nlm.nih.gov/pubmed/36575286 http://dx.doi.org/10.1007/s11604-022-01376-w |
Ejemplares similares
-
F-18-FDG PET/CT findings of paraneoplastic dermatoses
por: Suga, Kazuyoshi
Publicado: (2022) -
PET probes beyond (18)F-FDG
por: Jiang, Lei, et al.
Publicado: (2014) -
Do TSH, FT3, and FT4 Impact BAT Visualization of Clinical FDG-PET/CT Images?
por: Nishii, Ryuichi, et al.
Publicado: (2018) -
Imaging in Post-COVID Lung Disease: Does (18)F-FDG PET/CT Have the Key?
por: Gheysens, Olivier, et al.
Publicado: (2022) -
FDG-PET/CT finding of benign metastasizing leiomyoma of the lung
por: Nakajo, Masatoyo, et al.
Publicado: (2012)